Search Results - G. D. Alemanova

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    HYPOXIHYPOBAROTHERAPY IN REGULATION OF NEUROHUMORAL AND CYTOKINE RESPONSE IN REHABILITATION OF CHILDREN WITH BRONCHIAL ASTHMA by G.D. Alemanova

    Published 2009-10-01

    The effect of hypoxihypobarotherapy in children with bronchial asthma at the rehabilitation stage on the clinicals and dynamics of immunity response to the disease has been studied. Clinical efficacy of hypoxihypobarotherapy was 63,3% in moderate asthma. Positive dynamics of immunological indicators...

    Full description

    Get full text
    Article
  2. 2

    INTERMITTENT HYPOBARIC HYPOXIC STIMULATION IN TREATMENT OF CHILDREN WITH BRONCHIAL ASTHMA AT THE PERIOD OF REHABILITATION by G.D. Alemanova

    Published 2009-06-01

    Bronchial asthma is one of the widespread chronic diseases of lungs. Immune mechanisms of disorder are one of the causes which lead to pathologic changes in lungs. The aim: to determine the clinical and immunologic effectiveness of pressure adaptation to the periodical hypobaric hypoxic stimulation...

    Full description

    Get full text
    Article
  3. 3

    INFLUENCE OF ADAPTATION FOR PERIODIC HYPOBARIC HYPOXIC STIMULATION UPON CLINICAL AND IMMUNOLOGICAL EFFICIENCY IN THE CHILDREN WITH BRONCHIAL ASTHMA by G. D. Alemanova, A. I. Smolyagin, M. N. Volyanik, O. V. Volyanik, T. V. Dmitrieva

    Published 2014-07-01

    Abstract. The study performed has shown a positive clinical and immunological dynamics in forty children with medium-stage atopic bronchial asthma in remission stage, after a course of adaptation for periodical hypobaric hypoxic stimulation. These changes were expressed as a reduction in IgE, circul...

    Full description

    Get full text
    Article
  4. 4

    Experience of using the drug upadacitinib in a child with severe atopic dermatitis by G. D. Alemanova, L. Yu. Popova, E. A. Zlodeeva, O. V. Kirichenko, E. I. Pogrebnova

    Published 2025-06-01

    Introduction. Atopic dermatitis (AtD) is a genetically determined chronic dermatosis with heterogeneous manifestations that can significantly affect the quality of life of patients. The disease has a complex pathogenesis, which significantly complicates its treatment. The JAK-STAT signaling pathway...

    Full description

    Get full text
    Article